Suppr超能文献

四跨膜蛋白8在恶性胶质瘤中的过表达调控肿瘤细胞进展。

Over-expression of tetraspanin 8 in malignant glioma regulates tumor cell progression.

作者信息

Pan Si-Jian, Wu Yue-Bing, Cai Shang, Pan Yi-Xin, Liu Wei, Bian Liu-Guan, Sun Bomin, Sun Qing-Fang

机构信息

Department of Neurosurgery, Rui Jin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China.

Department of Internal Medicine Oncology, Hubei Cancer Hospital, Wuhan, Hubei 430079, China.

出版信息

Biochem Biophys Res Commun. 2015 Mar 13;458(3):476-482. doi: 10.1016/j.bbrc.2015.01.128. Epub 2015 Feb 11.

Abstract

Tumor cell invasion and proliferation remain the overwhelming causes of death for malignant glioma patients. To establish effective therapeutic methods, new targets implied in these processes have to be identified. Tetraspanin 8 (Tspn8) forms complexes with a large variety of trans-membrane and/or cytosolic proteins to regulate several important cellular functions. In the current study, we found that Tspn8 was over-expressed in multiple clinical malignant glioma tissues, and its expression level correlated with the grade of tumors. Tspn8 expression in malignant glioma cells (U251MG and U87MG lines) is important for cell proliferation and migration. siRNA-mediated knockdown of Tspn8 markedly reduced in vitro proliferation and migration of U251MG and U87MG cells. Meanwhile, Tspn8 silencing also increased the sensitivity of temozolomide (TMZ), and significantly increased U251MG or U87MG cell death and apoptosis by TMZ were achieved with Tspn8 knockdown. We observed that Tspn8 formed a complex with activated focal adhesion kinase (FAK) in both human malignant glioma tissues and in above glioma cells. This complexation appeared required for FAK activation, since Tspn8 knockdown inhibited FAK activation in U251MG and U87MG cells. These results provide evidence that Tspn8 contributes to the pathogenesis of glioblastoma probably by promoting proliferation, migration and TMZ-resistance of glioma cells. Therefore, targeting Tspn8 may provide a potential therapeutic intervention for malignant glioma.

摘要

肿瘤细胞的侵袭和增殖仍然是恶性胶质瘤患者死亡的主要原因。为了建立有效的治疗方法,必须确定这些过程中隐含的新靶点。四跨膜蛋白8(Tspn8)与多种跨膜和/或胞质蛋白形成复合物,以调节几种重要的细胞功能。在本研究中,我们发现Tspn8在多种临床恶性胶质瘤组织中过表达,其表达水平与肿瘤分级相关。Tspn8在恶性胶质瘤细胞(U251MG和U87MG细胞系)中的表达对细胞增殖和迁移很重要。siRNA介导的Tspn8敲低显著降低了U251MG和U87MG细胞的体外增殖和迁移。同时,Tspn8沉默还增加了替莫唑胺(TMZ)的敏感性,并且通过敲低Tspn8实现了TMZ显著增加U251MG或U87MG细胞死亡和凋亡。我们观察到,在人类恶性胶质瘤组织和上述胶质瘤细胞中,Tspn8与活化的粘着斑激酶(FAK)形成复合物。这种复合物的形成似乎是FAK激活所必需的,因为Tspn8敲低抑制了U251MG和U87MG细胞中的FAK激活。这些结果提供了证据,表明Tspn8可能通过促进胶质瘤细胞的增殖、迁移和TMZ抗性,从而促进胶质母细胞瘤的发病机制。因此,靶向Tspn8可能为恶性胶质瘤提供一种潜在的治疗干预措施。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验